Cargando…

Safety of Biologic-DMARDs in Rheumatic Musculoskeletal Disorders: A Population-Based Study over the First Two Waves of COVID-19 Outbreak

This study aims to explore disease patterns of coronavirus disease (COVID-19) in patients with rheumatic musculoskeletal disorders (RMD) treated with immunosuppressive drugs in comparison with the general population. The observational study considered a cohort of RMD patients treated with biologic d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sonaglia, Arianna, Comoretto, Rosanna, Pasut, Enrico, Treppo, Elena, Del Frate, Giulia, Colatutto, Donatella, Zabotti, Alen, De Vita, Salvatore, Quartuccio, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316145/ https://www.ncbi.nlm.nih.gov/pubmed/35891442 http://dx.doi.org/10.3390/v14071462

Ejemplares similares

Post-COVID-19 Arthritis and Sacroiliitis: Natural History with Longitudinal Magnetic Resonance Imaging Study in Two Cases and Review of the Literature
por: Colatutto, Donatella, et al.
Publicado: (2021)

Normal-Appearing Salivary Gland Ultrasonography Identifies a Milder Phenotype of Primary Sjögren's Syndrome
por: Zandonella Callegher, Sara, et al.
Publicado: (2020)

Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: A population-based study in the first two months of COVID-19 outbreak in Italy
por: Quartuccio, Luca, et al.
Publicado: (2020)

Risk of serious infection among patients receiving biologics for chronic inflammatory diseases: Usefulness of administrative data
por: Quartuccio, Luca, et al.
Publicado: (2018)

Articular and Peripheral Nervous System Involvement Are Linked to the Long-Term Outcome in Primary Sjögren's Syndrome: The Relevance of Single Organ Manifestations Rather Than a Composite Score as Predictors
por: Quartuccio, Luca, et al.
Publicado: (2019)

Healthcare and economic burden of ANCA-associated vasculitis in Italy: an integrated analysis from clinical and administrative databases
por: Quartuccio, Luca, et al.
Publicado: (2020)

High Throughput Genetic Characterisation of Caucasian Patients Affected by Multi-Drug Resistant Rheumatoid or Psoriatic Arthritis
por: Tesolin, Paola, et al.
Publicado: (2022)

Prévalence du COVID-19 chez les patients atteints de rhumatismes inflammatoires chroniques traités par biothérapies ou inhibiteurs des JAK : une étude basée sur la population au cours des deux premiers mois de l’épidémie de COVID-19 en Italie()
por: Quartuccio, Luca, et al.
Publicado: (2021)

Rituximab Induction and Maintenance in ANCA-Associated Vasculitis: State of the Art and Future Perspectives
por: Treppo, Elena, et al.
Publicado: (2021)

Psychological Effects of Lockdown Measures for the COVID-19 Outbreak in Patients with Systemic Lupus Erythematosus
por: Quartuccio, Luca, et al.
Publicado: (2021)

Ultrasound and Bioptic Investigation of Patients with Primary Sjögren’s Syndrome
por: Manfrè, Valeria, et al.
Publicado: (2021)

Clinical, laboratory and immunohistochemical characterization of in situ pulmonary arterial thrombosis in fatal COVID-19
por: Quartuccio, Luca, et al.
Publicado: (2022)

The Digital Way to Intercept Psoriatic Arthritis
por: Giovannini, Ivan, et al.
Publicado: (2021)

Safety, patient acceptance and diagnostic accuracy of ultrasound core needle biopsy of parotid or submandibular glands in primary Sjögren’s syndrome with suspected salivary gland lymphoma
por: Giovannini, Ivan, et al.
Publicado: (2022)

Sjögren syndrome: looking forward to the future
por: Zandonella Callegher, Sara, et al.
Publicado: (2022)

Mortality related to COVID-19 in patients with rheumatic and musculoskeletal diseases, first wave of the outbreak: a single-center study
por: Nuñez, Dalifer Freites, et al.
Publicado: (2022)

Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases
por: Trefond, Ludovic, et al.
Publicado: (2021)

Optical tomographic imaging discriminates between disease-modifying anti-rheumatic drug (DMARD) and non-DMARD efficacy in collagen antibody-induced arthritis
por: Peterson, Jeffrey D, et al.
Publicado: (2010)

Does COVID-19 cause an increased risk of hospitalization or death in patients with inflammatory rheumatic diseases treated with biological DMARDs or targeted synthetic DMARDs?
por: Lwin, May, et al.
Publicado: (2020)

Risk of Cancer in Connective Tissue Diseases in Northeastern Italy over 15 Years
por: Treppo, Elena, et al.
Publicado: (2022)

Characteristics and evolution of 38 patients with rheumatic diseases and COVID-19 under DMARD therapy
por: Galarza-Delgado, Dionicio Ángel, et al.
Publicado: (2020)

Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care
por: Quartuccio, Luca, et al.
Publicado: (2020)

Unmet needs in ANCA-associated vasculitis: Physicians’ and patients’ perspectives
por: Quartuccio, Luca, et al.
Publicado: (2023)

Arthritis Interception in Patients with Psoriasis Treated with Guselkumab
por: Zabotti, Alen, et al.
Publicado: (2021)

Structured report improves radiology residents’ performance in reporting chest high-resolution computed tomography: a study in patients with connective tissue disease
por: Cereser, Lorenzo, et al.
Publicado: (2022)

Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia
por: Quartuccio, Luca, et al.
Publicado: (2021)

Changes in the use patterns of bDMARDs in patients with rheumatic diseases over the past 13 years
por: Sánchez-Piedra, Carlos, et al.
Publicado: (2021)

Neurology of musculoskeletal and rheumatic disorders /
por: Nakano, Kenneth K.
Publicado: (1979)

Axial Psoriatic Disease: Clinical and Imaging Assessment of an Underdiagnosed Condition
por: Giovannini, Ivan, et al.
Publicado: (2021)

Salivary Gland Ultrasound in Primary Sjögren’s Syndrome: Current and Future Perspectives
por: Lorenzon, Michele, et al.
Publicado: (2022)

HBV and targeted synthetic (ts)DMARDs: what have we learned from bDMARDs and tsDMARDs?
por: Gremese, Elisa, et al.
Publicado: (2020)

Clinical factors associated with discontinuation of ts/bDMARDs in rheumatic patients from the BIOBADASER III registry
por: Prior-Español, A., et al.
Publicado: (2021)

Evaluation of the Synovial Effects of Biological and Targeted Synthetic DMARDs in Patients with Psoriatic Arthritis: A Systematic Literature Review and Meta-Analysis
por: Ciliento, Maria Sofia, et al.
Publicado: (2023)

Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity
por: Prawjaeng, Juthamas, et al.
Publicado: (2023)

Seronegative rheumatic arthritis has milder inflammation and bone erosion in an ultrasound study of disease-modifying anti-rheumatic drugs (DMARDs)-naïve Chinese cohort
por: Lin, Dongfang, et al.
Publicado: (2022)

Advancing frontiers in rheumatic and musculoskeletal imaging
por: Albano, Domenico, et al.
Publicado: (2021)

Musculoskeletal ultrasound for treating rheumatoid arthritis to target—a systematic literature review
por: Silvagni, Ettore, et al.
Publicado: (2022)

Outcomes with Biological Disease-Modifying Anti-Rheumatic Drugs (bDMARDs) in Older Patients Treated for Rheumatoid Arthritis
por: Akter, Ripa, et al.
Publicado: (2020)

Saudi cultural adaptation of the “compliance questionnaire of Rheumatology” for Rheumatoid arthritis patients on disease modifying anti-rheumatic drugs (DMARDs)
por: Aljohani, Roaa, et al.
Publicado: (2021)

Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs)
por: Adami, Giovanni, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d4gfc25nmjjmq8l96mot2k9hfh